Global CRO Reach Novotech operates a global clinical research footprint spanning 30+ offices and 5,000+ trial sites, presenting a scalable partner for sponsors seeking diverse patient populations and multi-region trials.

Awards & Trust Consistent Frost & Sullivan CRO of the Year recognition for 19 years, plus recent excellence awards in R&D and marketing, signaling strong credibility to potential sponsors and a proven track record.

Strategic Partnerships Recent collaborations with The START Center and Marvel Biotechnology indicate active expansion into early-phase oncology and neurodevelopmental programs, offering entry points for sponsors in high-growth therapeutic areas.

Digital & Global Ops Adoption of digital trial delivery platforms (e.g., ObvioGo) and modern tech stack (Oracle HCM, React, C#) suggests efficiency gains and potential for scalable, remote-enabled trials appealing to cost-conscious sponsors.

Leadership & Growth New CEO appointment in 2026 and continued rapid client acquisition (new clients like Marvel Biosciences) indicate a growth trajectory with opportunities for strategic co-investment, expanded scope, and longer-term partnerships.